Nexvet Biopharma (NVET) Provides Additional NV-01 Data at Investor Day; Cowen Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Nexvet to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 24, 2015 5:30 AM ESTDUBLIN, Ireland, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq: NVET), a veterinary biologics developer, today announced that Dr. Mark Heffernan, Nexvet's Chief Executive Officer, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York on Wednesday, December 2nd, at 2:30PM ET.
Dr. Heffernan will provide an overview of Nexvet's pioneering... More
Nexvet to Present at the 27th Annual Piper Jaffray Healthcare Conference
November 24, 2015 5:30 AM ESTDUBLIN, Ireland, Nov. 24, 2015 (GLOBE NEWSWIRE) -- Nexvet Biopharma (Nasdaq: NVET), a veterinary biologics developer, today announced that Dr. Mark Heffernan, Nexvet's Chief Executive Officer, is scheduled to present at the 27th Annual Piper Jaffray Healthcare Conference in New York on Wednesday, December 2nd, at 2:30PM ET.
Dr. Heffernan will provide an overview of Nexvet's pioneering... More
Nexvet Biopharma plc (Nasdaq: NVET) to Ring The Nasdaq Stock Market Closing Bell
November 23, 2015 6:00 AM ESTADVISORY, Nov. 23, 2015 (GLOBE NEWSWIRE) --
What:Â Nexvet Biopharma plc (Nasdaq: NVET), a global, clinical-stage, veterinary biologics developer, will visit the Nasdaq MarketSite in Times Square to celebrate the successful completion of a pivotal study for NV-01, its biologic therapy in development for the control of pain associated with osteoarthritis in dogs.
In honor of the occasion, the co-founders of Nexvet, Dr. Mark Heffernan, Chief Executive Officer and Dr. David Gearing, Chief Scientific Officer, will ring the Closing Bell.Â
Where:Â Nasdaq MarketSite 4 Times Square... More
Nexvet Biopharma plc (Nasdaq: NVET) to Ring The Nasdaq Stock Market Closing Bell
November 23, 2015 6:00 AM ESTADVISORY, Nov. 23, 2015 (GLOBE NEWSWIRE) --
What:Â Nexvet Biopharma plc (Nasdaq: NVET), a global, clinical-stage, veterinary biologics developer, will visit the Nasdaq MarketSite in Times Square to celebrate the successful completion of a pivotal study for NV-01, its biologic therapy in development for the control of pain associated with osteoarthritis in dogs.
In honor of the occasion, the co-founders of Nexvet, Dr. Mark Heffernan, Chief Executive Officer and Dr. David Gearing, Chief Scientific Officer, will ring the Closing Bell.Â
Where:Â Nasdaq MarketSite 4 Times Square... More
